Medicine and Dentistry
Periprosthetic Joint Infection
100%
Infection
68%
Neoplasm
49%
Diagnosis
45%
Prosthetics
43%
Antibiotics
42%
Hip
42%
Chondrosarcoma
41%
Osteosarcoma
41%
Pronation
39%
Cartilage Tumor
38%
Infectious Arthritis
38%
Supination
34%
Orthopedics
34%
Surgery
33%
Forearm Fracture
32%
Debridement
30%
Injury
30%
Prosthesis
29%
Bone Cancer
28%
Pediatrics
28%
Sarcoma
28%
Calgranulin
28%
Implant
24%
Arthroplasty
24%
Curettage
22%
Recurrent Disease
21%
Biological Marker
21%
Knee
20%
Prospective Study
19%
Lower Limb
19%
Oncology
19%
Computer Assisted Surgery
19%
Radiofrequency Ablation
19%
Limb Salvage
19%
Prospective Cohort Study
19%
Osteomyelitis
19%
Symptom
17%
Ewing Sarcoma
16%
Angulation
15%
Leukocyte
15%
Prevalence
15%
Magnetic Resonance Imaging
14%
Surgeon
14%
Adolescent
13%
Observational Study
13%
Retrospective Cohort Study
13%
Joint Prosthetics
12%
Biopsy
12%
Catheter Ablation
12%
Keyphrases
Periprosthetic Joint Infection
53%
Bone Sarcoma
23%
Antibiotics
21%
Pediatric Fracture
19%
Debridement
15%
Netherlands
12%
Initial Treatment
11%
Pediatric Forearm Fracture
11%
Implant Retention
11%
Bone Tumor
11%
Retrospective Cohort Study
11%
Distant Metastasis
11%
Bone Infection
10%
Joint Infection
10%
Intraoperative Cultures
10%
Sarcoma Care
9%
Forearm
9%
Orthopaedic Oncologist
9%
Multicentric Validation
9%
Follow-up Interval
9%
Lower Limb Salvage
9%
Range of Motion
9%
Spinal Instrumentation
9%
Validation Studies
9%
Galeazzi Fracture
9%
Halo
9%
Radiofrequency Ablation
9%
Clinical Practice
9%
Posttraumatic Stress Symptoms
9%
Bioactive Glass S53P4
9%
Osteomyelitis Treatment
9%
Long Bone Osteomyelitis
9%
Gentamicin
9%
Prophylactic Antibiotics
9%
High-grade Osteosarcoma
9%
Prosthesis
9%
Periosteal Chondrosarcoma
9%
Functional Recovery
9%
Cartilaginous Tumor
9%
Perceived Limitations
9%
F-18 Fluorodeoxyglucose Positron Emission Tomography
9%
Time to Positivity
9%
Both-bone Forearm Fracture
9%
Alignment Loss
9%
Surgical Debridement
9%
Multicenter Randomized Controlled Trial
9%
Functional Alternatives
9%
Total Femur Replacement
9%
Total Hip Prosthesis
9%
Oncologic
9%